After Hours Summary: AEO +14%, URBN +7%, CRM +6%, CSCO +6% following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: AEO +14.3%, URBN +7.3%, CRM +6.3%, CSCO +6.1%, BOOT +1.8%
Companies trading higher in after hours in reaction to news: RPRX +24.7% (reports 'positive' clinical data for Oral Proellex), ZIOP +6.7% (to present interim results from its ongoing Phase 1, multi-center dose-escalation study of the gene therapy candidate Ad-RTS-hIL-12 + orally-administered veledimex in patients with recurrent or progressive glioblastoma at ASCO), GALE +2.7% (to present primary analysis from the Company's GALE-301 Phase 1/2a clinical trial at ASCO), ARRY +2.4% (to present present additional data on its late-stage candidates binimetinib and encorafenib in NRAS-mutant melanoma and BRAF-mutant colorectal cancer at ASCO)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: DRWI -21.6%, LB -5.5%
Companies trading lower in after hours in reaction to news: HK -58.6% (reaches agreement to restructure balance sheet with select note holders for the potential elimination of ~$1.8 bln of debt & ~$222 mln of preferred equity while reducing interest burden by more than $200 mln), ARIA -1.8% (to present clinical data on brigatinib at ASCO)